Insulet Corporation - Common Stock — Cash Flow (NASDAQ:PODD) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities 84 M-68.1 M119 M145.7 M430.3 M569.3 M 511.2 M Cash from investing activities 14 M-82.7 M-191.1 M-119.4 M-146.2 M-222.7 M -248.9 M Cash from financing activities 605.5 M40.7 M-40.3 M-13.6 M-28.1 M-595.3 M -845.4 M Free cash flow 84 M-68.1 M119 M145.7 M430.3 M349.9 M 274.2 M

News

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking - Abbott Laboratories (N

Is Wall Street Bullish or Bearish on Insulet Stock?

Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?

Embecta: Excellent Turnaround Prospect In Defensive Medical Products (NASDAQ:EMBC)

Here's Why Insulet (PODD) is a Strong Value Stock

PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down

These Analysts Slash Their Forecasts On Insulet After Q2 Results - Insulet (NASDAQ:PODD)

Nasdaq Futures Slip as Western Digital and Sandisk Sink on Disappointing Guidance

Stock Indices Fall from Early Highs and Settle Mixed

Stocks Supported by Stellar Earnings

Strong Earnings Push the S&P 500 to New Record High

Insulet (PODD) Reports Q2 Earnings: What Key Metrics Have to Say